The enemy of my enemy is my friend—even in the retail and cloud computing businesses.
Cyber breaches caused by people within businesses and organizations, both accidental and malicious leaks, continue to multiply. Now, a Boston security startup is arming itself with more cash and enhanced technology to try and stop these insider threats.
ObserveIT announced... Read more »
High Alpha, an Indianapolis venture capital fund and startup “studio,” announced today that it has raised more than $100 million for two new funds called High Alpha Capital II and High Alpha Studio II.
High Alpha Capital backs companies the... Read more »
Telkonet, a small Milwaukee-area energy management and connected devices company, said this week it had hired the investment bank Roth Capital Partners “to explore strategic alternatives” with the goal of maximizing shareholder value.
Jason Tienor, president and CEO of Telkonet (OTCMKTS:... Read more »
It’s time to catch up on Boston tech headlines. This week, we’re tracking acquisitions by Autodesk and DataRobot, a $100 million investment in upstart wireless Internet provider Starry, a new startup from Runkeeper co-founder Jason Jacobs, details about a stealthy autonomous... Read more »
Semiconductor maker Broadcom, which ended its effort to buy competitor Qualcomm earlier this year, has a new target: New York-based business software maker CA Technologies.
PactSafe, an Indianapolis startup focused on cloud-based contracting services, announced this week that it has raised a $5.5 million Series A investment round. The round was co-led by Houston, TX-based Mercury Fund and Salt Lake City’s Signal Peak Ventures,... Read more »
Otsuka Pharmaceutical is expanding its pipeline and U.S. reach with an agreement to acquire Waltham, MA, clinical-stage drug developer Visterra for $430 million in cash.
Catalina Kaiyoorawongs knows from experience how dire the student debt crisis has gotten in the United States.
She spent years addressing access to loans for fellow low-income and first-generation students in Florida as part of her advocacy work, calling financial aid... Read more »
BioCryst Pharmaceuticals is ending a plan to merge with Idera Pharmaceuticals and form a single company focused on rare diseases.